tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market

Cardiol Therapeutics (CRDL) Income Statement

Compare
374 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q4 2024), Cardiol Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Cardiol Therapeutics's net income was C$-8.18M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 78.76KC$ 0.00
Gross Profit
C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76KC$ -229.54K
Operating Expenses
C$ 39.90MC$ 29.54MC$ 41.34MC$ 38.74MC$ 20.69M
Depreciation and Amortization
C$ 373.11KC$ 248.35KC$ 219.91KC$ 220.42KC$ 229.54K
EBITDA
C$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44MC$ -20.41M
Operating Income
C$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47MC$ -20.61M
Other Income/Expenses
C$ 3.60MC$ 1.66MC$ 10.41MC$ 7.03MC$ 49.53K
Pretax Income
C$ -36.68MC$ -28.13MC$ -30.93MC$ -31.64MC$ -20.64M
Net Income
C$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72MC$ -20.65M
Per Share Metrics
Basic EPS
C$ -0.51C$ -0.44C$ -0.18C$ -0.57C$ -0.69
Diluted EPS
C$ -0.51C$ -0.44C$ -0.18C$ -0.57C$ -0.69
Weighted Average Shares Outstanding
71.57M 64.46M 62.51M 43.22M 29.86M
Weighted Average Shares Outstanding (Diluted)
71.57M 64.46M 62.51M 43.22M 29.86M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis